Jørgensen B G, Qvist N
Odense Universitetshospital, kirurgisk afdeling A.
Ugeskr Laeger. 2001 Feb 12;163(7):895-8.
Allogenic blood transfusion carries the risk of immunological and non-immunological adverse effects. Consequently, blood transfusion should be limited to situations where alternatives are not available. This article reviews current by available alternative strategies that reduce the need for perioperative allogenic blood transfusion. The effectiveness of a number of these alternatives needs to be documented and potential adverse effects clarified. The acceptance of a lower haemoglobin level as the transfusion trigger value is perhaps the most important factor in reducing the need for peri-operative allogenic blood transfusion.
异体输血存在免疫和非免疫不良反应的风险。因此，输血应仅限于没有其他替代方法的情况。本文综述了目前可用的减少围手术期异体输血需求的替代策略。其中一些替代方法的有效性需要得到证实，潜在的不良反应也需要明确。接受较低的血红蛋白水平作为输血触发值可能是减少围手术期异体输血需求的最重要因素。
